Loss-of-function DJ-1 (PARK7) mutations have been linked with a familial form of early onset Parkinson disease. Numerous studies have supported the role of DJ-1 in neuronal survival and function. Our initial studies using DJ-1-deficient neurons indicated that DJ-1 specifically protects the neurons against the damage induced by oxidative injury in multiple neuronal types and degenerative experimental paradigms, both in vitro and in vivo. However, the manner by which oxidative stress-induced death is ameliorated by DJ-1 is not completely clear. We now present data that show the involvement of DJ-1 in modulation of AKT, a major neuronal prosurvival pathway induced upon oxidative stress. We provide evidence that DJ-1 promotes AKT phosphorylation in response to oxidative stress induced by H 2 O 2 in vitro and in vivo following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Moreover, we show that DJ-1 is necessary for normal AKT-mediated protective effects, which can be bypassed by expression of a constitutively active form of AKT. Taken together, these data suggest that DJ-1 is crucial for full activation of AKT upon oxidative injury, which serves as one explanation for the protective effects of DJ-1.
Loss-of-function DJ-1 (PARK7) mutations have been linked with a familial form of early onset Parkinson disease. Numerous studies have supported the role of DJ-1 in neuronal survival and function. Our initial studies using DJ-1-deficient neurons indicated that DJ-1 specifically protects the neurons against the damage induced by oxidative injury in multiple neuronal types and degenerative experimental paradigms, both in vitro and in vivo. However, the manner by which oxidative stress-induced death is ameliorated by DJ-1 is not completely clear. We now present data that show the involvement of DJ-1 in modulation of AKT, a major neuronal prosurvival pathway induced upon oxidative stress. We provide evidence that DJ-1 promotes AKT phosphorylation in response to oxidative stress induced by H 2 O 2 in vitro and in vivo following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Moreover, we show that DJ-1 is necessary for normal AKT-mediated protective effects, which can be bypassed by expression of a constitutively active form of AKT. Taken together, these data suggest that DJ-1 is crucial for full activation of AKT upon oxidative injury, which serves as one explanation for the protective effects of DJ-1. (1, 2) . Although the physiological role of DJ-1 is not completely understood, several lines of evidence indicate a protective role for DJ-1 in multiple models of neuronal and nonneuronal oxidative stress-induced cell death (3) (4) (5) (6) (7) . For example, we have previously shown that genetic ablation of DJ-1 in mice hypersensitizes dopamine neurons to the toxic effects induced by the mitochondrial toxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). This sensitivity was reversed by the induction of virally delivered human DJ-1 (8) . These observations are in line with data by other groups showing sensitivity of dopaminergic neurons in DJ-1-deficient Drosophila models, as well as increased susceptibility to oxidative stress in vitro (9) (10) (11) . To further support the importance of DJ-1 in managing oxidative stress, we provided evidence showing that DJ-1 protects the brain against ischemic injury that models clinical stroke. Moreover, our data indicated a direct correlation between DJ-1 neuroprotective activity and the reduced levels of oxidized DNA nucleotide species, 8-oxo guanine, a marker of oxidative damage (12) .
Despite the fact that the neuroprotective role of DJ-1 has been consistently shown in multiple models of neurodegeneration, the exact mechanism of the neuroprotective function has not been fully elucidated. A direct antioxidant property of DJ-1 as a reactive oxygen species (ROS) scavenger has been proposed as a mechanism to overcome oxidative stress (7, 13) . In fact, recombinant human DJ-1 confers some ROS scavenging activity; however, this activity is much weaker than any known peroxidase, thus not fully explaining its neuroprotective function (10, 13) . Several alternative mechanisms to account for the neuroprotective function of DJ-1 have been suggested. For example, via its putative role in transcription regulation (14) , DJ-1 up-regulates the expression of other antioxidant genes, such as glutathione synthase, during oxidative stress (15) . Interestingly, it has also been reported that DJ-1 enhances the activity of the transcription factor Nrf2, a master regulator of antioxidant genes (16, 17) . Alternatively, DJ-1 has also been shown to modulate key signaling pathways (3, 10) . One signaling pathway implicated with DJ-1 function and relevant to the present work is AKT (10, 18) .
AKT is a member of a larger class of serine/threonine kinases called AGC [protein kinase A (AMP protein kinase), PKG (GMP protein kinase), and PKC]. AKT has an N-terminus pleckstrin homology domain that mediates the interaction of AKT with a plasma membrane phospholipid, phophatidylinositol 3,4,5-triphosphate (PIP3). Extensive studies have shown that recruitment of AKT to the plasma membrane, and its association with PIP3, is crucial for its activation (19, 20) . Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is particularly known for its action to convert PIP3 to phosphatidylinositol-4, 5-biphosphate (PIP2). This function of PTEN directly antagonizes PI3K to eventually down-regulate AKT (21, 22) . Several lines of evidence indicated that the AKT signaling pathway responds to oxidative stress (23) and exerts a neuroprotective function (24, 25) . Moreover, a large number of studies in vitro have illustrated that pharmacological compounds that protect cells against oxidative stress exert their neuroprotective effects through activation of the AKT pathway (26) (27) (28) (29) (30) .
Early studies described DJ-1 as a negative regulator of PTEN using a Drosophila genetic screen (31) . Evidence to confirm this negative regulation was demonstrated via down-regulation of DJ-1 using small interfering RNA, which resulted in the inhibition of endogenous AKT phosphorylation in cancer cell lines as well as in the Drosophila brain (10, 31, 32) . Furthermore, loss of DJ-1 has been shown to reduce AKT activation in response to hypoxia in murine embryonic fibroblasts (MEFs) (33) . However, the relevance of this pathway has yet to be shown in the context of neurons either in vitro or in vivo. Evidence to support a role for DJ-1 in the regulation of the AKT pathway would be particularly important when one considers the genetic linkage of DJ-1 to familial PD. Presently, we provide direct evidence, both in vitro and in vivo, that DJ-1 exerts an important role in the regulation of the AKT pathway in response to oxidative stress and neuronal protection. In addition, based on our results, we propose a mechanism suggesting that DJ-1 acts as an upstream regulator of AKT through membrane recruitment to confer neuroprotection. −/− compared to wild-type controls (1.19 ± 0.10 vs. 1.52 ± 0.14, respectively). There was no significant increase in AKT phosphorylation when comparing saline and MPTP treated DJ-1 −/− animals (1.00 ± 0.2 vs. 1.19 ± 0.10, respectively). To further confirm these results, we also examined AKT phosphorylation in response to H 2 O 2 in human lymphoblasts from human PD patients harboring DJ-1 mutations. As demonstrated in Fig. 1E , AKT response was significantly attenuated in L166P mutated cells compared to the controls.
Results

Phosphorylation of AKT in Response to
DJ-1 Is Necessary for AKT-Mediated Neuroprotective Function in Vitro
and in Vivo. We next evaluated the functional role of DJ-1 in the protective effects of AKT following oxidative stress. First, we examined the role of AKT in protecting neurons against oxidative stress induced by H 2 O 2 in vitro. Neurons, transfected with HA-tagged wild-type AKT along with GFP expression vectors as a marker of transfection (or GFP/empty vector transfection as control) were treated with H 2 O 2 , 24 h after transfection, and survival was assessed as described in Materials and Methods ( Fig.2A) . As shown in Fig. 2B , induction of exogenous wild-type AKT confers protection in DJ-1 +/+ neuronal cells in response to H 2 O 2 . Next, DJ-1 −/− cortical neurons were tested to examine whether induction of wild-type AKT could provide similar protection in DJ-1-deficient cells. Surprisingly, induction of exogenous AKT failed to protect DJ-1 −/− neurons against H 2 O 2 -induced death (Fig. 2C ). To confirm these observations, we cultured neurons harvested from DJ-1 −/− and DJ-1 +/+ litters at the same time. Three days after plating, the cells were transiently transfected with wild-type AKT together with or without a DJ-1 expression vector, DJ-1 only, or myristoylated AKT, a membraneanchored constitutively active form of AKT (34 ).
Suppression of AKT Abolishes the Neuroprotective Function of DJ-1 in
Vitro and in Vivo. The observations that DJ-1 deficiency reduces AKT activation and that wild-type AKT requires DJ-1 to effectively protect neurons against oxidative stress suggests DJ-1 acts as an upstream activator of AKT. We next determined whether DJ-1 exerts its neuroprotective effects, at least partially, through the AKT pathway. To examine this, we first used a conventional pharmacological inhibitor of AKT, LY294002 (LY) (35) . Because the basal activity of AKT is essential for the long-term health of cultured neurons, we determined the optimal dose of inhibitor that suppressed AKT with minimal toxicity to the cultured neurons (Fig. 3A) . We next infected cultured cortical neurons with adenoviral vectors expressing GFP only or DJ-1 and GFP on separate promoters at the time of plating. Thirty-six hours after plating, we pretreated the cells with 10-μM LY or vehicle for 30 min before application of H 2 O 2 or vehicle for 3 h. Cells were then assessed for survival. As shown in Fig. 3B , the neuroprotective activity of DJ-1 is significantly reduced upon suppression of AKT phosphorylation by LY (52.78 ± 0.20% vs. 40.55 ± 0.55%, respectively). We also used a more specific molecular strategy to validate our results by transiently transfecting a phosphorylation mutant, dominant-negative form (DN-AKT) of AKT (AAA-AKT) into cortical neurons. In this mutant, all phosphorylation sites of AKT have been mutated to alanine; therefore, this artificial mutant of AKT is incapable of being phosphorylated and displays dominant-negative properties toward endogenous AKT (21) . As shown in Fig. 3C , the results of this experiment confirmed that suppression of AKT diminished the neuroprotective function of DJ-1 (84.46 ± 2.90% without DN-AKT vs. 59.26 ± 2.01% with DN-AKT).
DJ-1 Is Necessary for AKT-Mediated Neuroprotection in Vivo Following
MPTP Treatment. In vitro experiments indicated that DJ-1 is necessary for AKT activation and is neuroprotective in response to H 2 O 2 . To confirm these results and to test this hypothesis in a more clinically relevant paradigm, we examined whether induction of wild-type AKT can protect nigrostriatal neurons against the dopaminergic specific neurotoxin MPTP in vivo. To achieve this, we injected adenoviral vectors harboring HA-tagged wildtype AKT or myristoylated AKT into the striatum of DJ-1 +/+ and DJ-1 −/− age-matched mice. β-gal expressing adenoviruses were used as control. As shown in Fig. 4 B and C, the virus localizes specifically to the ipsilateral side in dopamine neurons. One week after virus injection, we performed a subchronic MPTP treatment paradigm as indicated in Fig. 4A . Two weeks after the initial MPTP injection, animals in all groups were sacrificed and prepared for histological analysis. We first assessed survival by counting the number TH+ neurons of SNc at the level of the medial terminal nucleus (MTN) (Fig. 4E) . Consistent with our in vitro observations, DJ-1 +/+ animals that received wild-type HA-tagged AKT and were subjected to MPTP treatments showed larger number of surviving TH+ neurons in the ipsilateral side of virus injection, compared to the contralateral side (146.9 ± 8.5 vs. 109.9 ± 9.2, respectively). Meanwhile, there was no significant difference between ipsi-and contralateral sides of the SNc in the knockout animals that received HA-AKT. (88.2 ± 7.4 vs. 90.9 ± 8.0, respectively). To verify whether the loss of TH immunoreactivity was in fact a result of the death of dopaminergic neurons and not loss of expression, we stained for cresyl violet and assessed neuronal survival in the MTN region of the SNc. Similarly, a substantial rescue was observed in the wild-type mice (62.8 ± 1.9% vs. 50.7 ± 3.0%, ipsilateral vs. contralateral), whereas no protective effect was observed when injecting HA-AKT in the DJ-1 −/− mice (48.9 ± 3.0% vs. 51.9 ± 4.0% ipsilateral vs. contralateral) (Fig. S1 ). To further substantiate the SNc neuronal survival results, we examined whether prophylactic administration of virus could rescue dopaminergic terminals in the striatum of the animals subjected to MPTP injection in each group using expression of dopamine transporter (DAT) as a marker of dopaminergic terminals. Consistent with SNc results, higher densities, and thus greater survival of dopaminergic terminals, were observed following MPTP treatment in the striatum of virus-injected sides compared to the contralateral sides in the AKT-expressing group (97.0 ± 5.0 vs. 54.5 ± 7.6 for HA-AKT, respectively) (Fig. 4F) . Such protection was not observed in DJ-1 −/− animals, which signifies that the AKT-mediated neuroprotection is dependent upon the presence of DJ-1. In line with our observations in vitro and in vivo, myristoylated AKT (Myr-AKT) provides protection to both DJ-1 −/− and DJ-1 +/+ animals (87.5 ± 5.0 ipsilateral vs. 41.9 ± 5.2 contralateral, and 102.0 ± 7.1 ipsilateral vs. 64.7 ± 6.0 contralateral, respectively). All viruses were also injected without MPTP treatment to note effects of virus toxicity. No significant death of SNc neurons was attributed to viral vectors.
DJ-1 Modulates AKT Translocation to Membranous Fractions.
Our results in vitro and in vivo demonstrated specifically that myristoylated rather than a wild-type form of AKT promotes protection in DJ-1 −/− neurons. We therefore tested whether DJ-1 was affecting AKT translocation to membranous compartments following oxidative stress. This was done by determining the subcellular localization of AKT following H 2 O 2 treatment in DJ-1 +/+ and DJ-1 −/− neurons and MEFs. As shown in Fig. 5A , the H 2 O 2 -induced AKT localization to the membrane fraction is greatly decreased in the DJ-1 −/− compared with the DJ-1 +/+ MEFs. Quantification revealed AKT translocation to the membrane fraction following treatment that was 4-fold greater in the DJ-1 +/+ than in DJ-1 −/− cells (2.94 ± 1.14 vs. 0.78 ± 0.30, respectively). Similarly, in DJ-1 −/− neurons, no AKT translocation was observed following H 2 O 2 (0.58 ± 0.10-fold increase), whereas DJ-1 +/+ neurons showed an AKT translocation 5 min post-treatment (1.55 ± 0.37 fold increase) No significant differences were observed in levels of total AKT in the cytoplasmic fraction.
Discussion DJ-1 was first discovered as a weak oncogene with an unclear mechanism of action (36) . Since then, putative roles for DJ-1 have been proposed, which include functions in transcriptional regulation either via binding to and modulating an androgen receptor inhibitor, PIASx-alpha (37), as well as RNA-protein interactions (38) . The DJ-1 protein also displayed some homology to the proteins of the ThiJ/PfpI family of bacterial proteases (39, 40) , suggesting a putative chaperone function. Interestingly, DJ-1 was also noted to display an isoelectric pH shift upon induction of oxidative stress, potentially placing DJ-1 within the oxidative stress-response pathway. Despite these important implications, its physiological relevance was not entirely clear until its genetic linkage to PD. To this end, several themes regarding DJ-1 have now emerged that link this protein to neurodegeneration, PD, and oxidative stress. These themes include, but are not limited to the following: (i) DJ-1 protects neurons against oxidative stress (4, 9, 11, (41) (42) (43) (44) ; (ii) Loss of DJ-1 on its own does not lead to dopamine neuron death, at least in mice, but DJ-1-deficient animals are sensitized to environmental stress and exhibit impaired dopamine signaling (45) (46) (47) (48) ; and (iii) DJ-1 modulates signaling pathways critical to cell survival such as PTEN and AKT, at least in select nonneuronal contexts (31) .
In the present study, we more carefully characterized the necessity of DJ-1 for activation of the AKT pathway in response to oxidative injury, particularly in neurons. We first demonstrated that the absence of DJ-1 significantly attenuates AKT phosphorylation in vitro and in vivo, as well as in human lymphoblasts derived from PD patients harboring pathogenic DJ-1 mutations. Importantly, even though AKT phosphorylation is not completely abolished by loss of DJ-1, we also demonstrated that the significant attenuation in AKT signaling brought about by DJ-1 deficiency resulted in enhanced cell death both in vitro and in vivo. These data not only highlighted an important functional role for DJ-1 in AKT-mediated cell survival, but also indicated that the AKT pathway is integral to the mechanism of protection conferred by DJ-1 and suggested that DJ-1 could be an upstream regulator of AKT. In light of our findings above, together with the knowledge that AKT is considered to be part of the survival pathway, we sought to further investigate the nature of the DJ-1/AKT relationship. We first demonstrated that overexpression of AKT alone protects cultured neurons exposed to oxidative stress in vitro as well as dopamine neurons exposed to MPTP in vivo. Furthermore, inhibition of the PI3K/Akt pathway significantly reduces the protection that is conferred by DJ-1. Importantly, we also demonstrated that wildtype AKT required DJ-1 to exert its protective effect as DJ-1 deficiency abrogated the effect of AKT on cell survival. Interestingly, the protective effects of AKT in a DJ-1-deficient background can be bypassed using myristoylated AKT, its membrane-anchored constitutively active form. This latter observation is consistent with reports that membrane-bound AKT is sufficient to provide protection following MPP + treatment both in vitro (49) as well as 6-OHDA treatment in vivo (50) . Because AKT recruitment to the membrane is a prior event to its phosphorylation and activation (51, 52) , these results, in addition to the cell fractionation experiments presented in our study, suggested that DJ-1 permits AKT translocation to the membrane fractions.
Our study therefore proposes a working model in which DJ-1 acts upstream of AKT, thereby facilitating its activation following neuronal injury via oxidative stress. We propose that DJ-1 may be involved in fine-tuning the response of neurons to ROS and modulation of signaling pathways that mediate survival. In this regard, it will be critical in future studies to address the possible mechanisms underlying the ROS-mediated, DJ-1-dependent activation of AKT. One might consider the possibility that DJ-1 regulates AKT by modulating its recruitment to the membrane in a ROS-dependent manner. It is noteworthy that the AKT response to H 2 O 2 can be altered depending on antioxidant protein activity within the cell (53) (54) (55) . Thus, further studies in models that permit well-controlled ROS levels are needed to address these questions. However, other possibilities exist. For example, a recent study has suggested that DJ-1 interacts with PTEN to permit AKT activation, although this needs to be further investigated in more physiologically relevant models (56) . Additionally, DJ-1 may interact with other PI3K pathway kinases, such as mTOR and PDK, to permit AKT phosphorylation. Finally, while DJ-1 plays a significant role in facilitating AKT phosphorylation, other factors may also each play a role (21, 57, 58) . Thus, additional studies should be performed to investigate the nature of the DJ-1/ AKT interdependence.
Finally, it is interesting to note that even though it is clear that DJ-1 is linked to familial PD, there is a report of an epidemiological association with certain haplotype of AKT1 and a reduced risk of PD (59) . This observation provides further strength to the notion that the DJ-1/AKT signaling axis may be important in regulating dopaminergic function or death. Elucidation of these mechanisms may provide an eventual basis for neuroprotective therapies.
Materials and Methods
Cell culture, Western blot analysis, and in vivo stereotaxic injections and MPTP administration were performed as previously described (60) . All procedures involving animals were approved by the University of Ottawa Animal Care Committee and were maintained in strict accordance with the Guidelines for the Use and Treatment of Animals put forth by the Animal Care Council of Canada and endorsed by the Canadian Institutes of Health Research. For additional in vivo and in vitro procedures, see SI Materials and Methods. Subcellular Fractionation. Membrane fractions were obtained similarly for MEFs and DIV 6 cortical neurons using differential centrifugation. Briefly, cells were harvested in cold PBS and centrifuged at 1,200 × g for 3 min. The cell pellet was resuspended in 200 μL of hypo-osmolar buffer [50 mM Tris-HCl, pH 7.4; 50 mM NaCl; protease inhibitor complex (Roche)] and homogenized for 30 s. Samples were centrifuged at 20,000 × g, at 4°C for 20 min. Supernatants (cellular debris) were transferred to 1.5-mL ultracentrifuge tubes (Beckman) and centrifuged at 100,000 × g, at 4°C for 3 h. The pellets (microsomal enriched) were resuspended in RIPA buffer (150 mM NaCl; 1% Nonidet P-40; 0.5% deoxycholic acid; 0.1% SDS; 50 mM Tris-HCl, pH 8.0) and sonicated briefly for subsequent Western blot analysis. Supernatants from final spin were used as a cytoplasmic control.
Statistical Analysis. Statistical significance was either determined by Student's t-test or one-way ANOVA followed by Tukey's post hoc test. All data are presented as mean ± SEM. Significance at P < 0.05 (*) and P < 0.01 (**), and NS denotes no significant difference.
